Copper‐Curcumin‐Bipyridine Dicarboxylate Complexes as Anticancer Candidates
Abstract In this study, copper complexes with Curcumin (Cur) and 2,2’‐bipyridine‐5,5’‐dicarboxylic acid (BPYD) were synthesized and their cytotoxicity on the MDA‐MB‐231 cell lines was evaluated. The resulting complex was characterized using FTIR, UV/VIS, CHNS, TGA, ICP‐MS, and Mass spectroscopy techniques. The in‐vitro cytotoxicity was studied on the MDA‐MB‐231 as a cancerous cell line and the HUVEC as a normal cell line. Reactive oxygen species (ROS) production was measured using the 2′,7′‐dichlorofluorescein diacetate (DCFDA) test in the MDA‐MB‐231 cancer cell lines. The in‐vitro assays revealed that all synthesized copper complexes exhibited a higher cytotoxicity effect than carboplatin as a positive control on the MDA‐MB‐231 cells. While the synthesized complexes exhibited cytotoxic effects on cancerous cell lines, they are practically safe on normal cells. The Cu‐Cur‐BPYD complexes ( a5& b5) exhibited higher cytotoxicity on MDA‐MB‐231 cells with IC50 s around 4.9 and 2.3 mM, respectively. It can be concluded that the synthesized Cu‐Cur‐BPYD complexes ( a5& b5) could be considered effective anticancer candidates in complementary studies..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Chemistry & Biodiversity - 19(2022), 10 |
| Beteiligte Personen: |
Emami, Fatemeh [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2022 Wiley‐VHCA AG, Zurich, Switzerland |
|---|
| Umfang: |
13 |
|---|
| doi: |
10.1002/cbdv.202200202 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY003120015 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY003120015 | ||
| 003 | DE-627 | ||
| 005 | 20230307123957.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230213s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/cbdv.202200202 |2 doi | |
| 028 | 5 | 2 | |a CBDV_CBDV202200202.xml |
| 035 | |a (DE-627)WLY003120015 | ||
| 035 | |a (WILEY)CBDV202200202 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 570 |a 540 |q ASE |
| 082 | 0 | 4 | |a 570 |a 540 |q ASE |
| 084 | |a 42.90 |2 bkl | ||
| 084 | |a 43.12 |2 bkl | ||
| 100 | 1 | |a Emami, Fatemeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Copper‐Curcumin‐Bipyridine Dicarboxylate Complexes as Anticancer Candidates |
| 264 | 1 | |c 2022 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 Wiley‐VHCA AG, Zurich, Switzerland | ||
| 520 | |a Abstract In this study, copper complexes with Curcumin (Cur) and 2,2’‐bipyridine‐5,5’‐dicarboxylic acid (BPYD) were synthesized and their cytotoxicity on the MDA‐MB‐231 cell lines was evaluated. The resulting complex was characterized using FTIR, UV/VIS, CHNS, TGA, ICP‐MS, and Mass spectroscopy techniques. The in‐vitro cytotoxicity was studied on the MDA‐MB‐231 as a cancerous cell line and the HUVEC as a normal cell line. Reactive oxygen species (ROS) production was measured using the 2′,7′‐dichlorofluorescein diacetate (DCFDA) test in the MDA‐MB‐231 cancer cell lines. The in‐vitro assays revealed that all synthesized copper complexes exhibited a higher cytotoxicity effect than carboplatin as a positive control on the MDA‐MB‐231 cells. While the synthesized complexes exhibited cytotoxic effects on cancerous cell lines, they are practically safe on normal cells. The Cu‐Cur‐BPYD complexes ( a5& b5) exhibited higher cytotoxicity on MDA‐MB‐231 cells with IC50 s around 4.9 and 2.3 mM, respectively. It can be concluded that the synthesized Cu‐Cur‐BPYD complexes ( a5& b5) could be considered effective anticancer candidates in complementary studies. | ||
| 700 | 1 | |a Aliomrani, Mehdi |4 aut | |
| 700 | 1 | |a Tangestaninejad, Shahram |4 aut | |
| 700 | 1 | |a Kazemian, Hossein |4 aut | |
| 700 | 1 | |a Moradi, Mohammadmahdi |4 aut | |
| 700 | 1 | |a Rostami, Mahboubeh |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemistry & Biodiversity |g 19(2022), 10 |w (DE-627)WLY003111520 |x 16121880 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:10 |g extent:13 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-GGO | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 42.90 |q ASE |
| 936 | b | k | |a 43.12 |q ASE |
| 951 | |a AR | ||
| 952 | |d 19 |j 2022 |e 10 |g 13 | ||